Iodoxyd (Suppositories) Instructions for Use
Marketing Authorization Holder
Nizhpharm JSC (Russia)
Contact Information
NIZHPHARM group of companies (Russia)
ATC Code
G01AX11 (Povidone-iodine)
Active Substance
Povidone-iodine
Dosage Form
| Iodoxyd | Vaginal suppositories 200 mg: 10 or 15 pcs. |
Dosage Form, Packaging, and Composition
Vaginal suppositories brown with a brownish tint, torpedo-shaped, marbling of the surface is allowed.
| 1 supp. | |
| Povidone-iodine (iodine in the form of a polyvinylpyrrolidone-iodine complex) | 200 mg |
Excipients: polyethylene oxide 1500, polyethylene oxide 400.
5 pcs. – contour cell packs (2) – cardboard packs.
5 pcs. – contour cell packs (3) – cardboard packs.
Clinical-Pharmacological Group
Topical antiseptic for use in gynecology
Pharmacotherapeutic Group
Antiseptic
Pharmacological Action
An antiseptic for topical use in gynecology. It blocks the amino groups of cellular proteins. It has a broad spectrum of antimicrobial action.
Active against bacteria (including Escherichia coli, Staphylococcus aureus), fungi, viruses, protozoa.
The active substance of the drug – iodine – is in the form of a complex with polyvinylpyrrolidone (povidone), which belongs to iodophors that bind iodine. The concentration of active iodine is 0.1-1%. Upon contact with the skin and mucous membranes, iodine is gradually and evenly released, exerting a bactericidal effect on microorganisms. A thin colored layer remains at the application site, which persists until all the iodine is released.
Pharmacokinetics
Data on the pharmacokinetics of Iodoxyd are not provided.
Indications
- Treatment of acute and chronic infectious and inflammatory diseases of the vagina (trichomonal, fungal, viral, nonspecific, mixed infections), bacterial vaginitis;
- Prevention of infectious and inflammatory complications before gynecological interventions (artificial termination of pregnancy, insertion and removal of an intrauterine device, diathermocoagulation of the cervix, hysterosalpingography).
ICD codes
| ICD-10 code | Indication |
| A59 | Trichomoniasis |
| B37.3 | Candidiasis of vulva and vagina |
| N76 | Other inflammatory diseases of vagina and vulva |
| N77.1 | Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere |
| Z51.4 | Preparatory procedures for subsequent treatment or examination, not elsewhere classified |
| ICD-11 code | Indication |
| 1A92 | Trichomoniasis |
| 1F23.10 | Candidiasis of vulva and vagina |
| 1F65 | Enterobiasis |
| 1H0Z | Unspecified infection |
| GA00 | Vulvitis |
| GA02.Z | Unspecified vaginitis |
| GA0Z | Inflammatory diseases of female genital tract, unspecified |
| QB9A | Preparatory procedures for subsequent treatment |
| 1A94.0 | Genital or urogenital tract infection caused by Herpes simplex virus |
| GA41 | Ulcerative or erosive diseases of vulva |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
For acute vaginitis, administer 1 suppository twice daily for 7 days.
For subacute and chronic vaginitis, administer 1 suppository once daily at bedtime for 14 days.
Apply the regimen regardless of the menstrual cycle phase.
For prevention of infectious complications before gynecological procedures, follow the specific regimen and duration prescribed by a physician.
Insert the suppository deep into the vagina while in a supine position.
Thoroughly wash hands before and after the administration procedure.
Use a panty liner during treatment, as the suppository may cause staining.
Complete the full course of treatment as directed, even if symptoms improve earlier.
Consult a physician if no improvement is observed within the specified treatment period.
Adverse Reactions
Allergic reactions: itching, hyperemia.
Contraindications
- Concurrent therapy with radioactive iodine;
- Duhring’s dermatitis herpetiformis;
- Thyroid adenoma;
- Thyrotoxicosis;
- Newborns;
- Hypersensitivity to the components of the drug.
Use with caution in chronic renal failure.
Use in Pregnancy and Lactation
Use of the drug in the II and III trimesters of pregnancy is possible only if the intended benefit to the mother outweighs the potential risk to the fetus.
The drug should be used with caution during lactation.
Use in Renal Impairment
Use with caution in chronic renal failure.
Special Precautions
In the presence of blood, the bactericidal effect of the drug may decrease.
In case of non-manifest hyperthyroidism and other thyroid diseases (especially in elderly patients), the drug should be used only under strict indications and with constant medical supervision.
Avoid contact with eyes.
Overdose
Data on overdose of Iodoxyd are not provided.
Drug Interactions
Iodoxyd is incompatible with disinfectants, mercury-containing preparations, oxidizing agents, alkalis, and substances with an acidic reaction.
Storage Conditions
List B. The drug should be stored in a dry, light-protected place, out of the reach of children, at a temperature not exceeding 20°C (68°F).
Shelf Life
Shelf life – 2 years.
Dispensing Status
The drug is approved for use as an over-the-counter product.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Arbidol, capsules 100mg, 40pcs
Noopept, pills 10mg, 50pcs
Fenotropil pills 100mg, 60pcs
Picamilon pills 50mg, 60pcs
Actovegin pills 200mg, 50pcs
Belosalic, ointment, 30g
Phenibut-Vertex pills 250mg, 20pcs
Nootropil pills 800mg, 30pcs
Daivobet, ointment, 30g
Ingavirin capsules 90mg, 10pcs
Kagocel pills 12mg, 30pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Cortexin, 10mg, 5ml, 10pcs
Belosalic, lotion solution for external use spray 100ml 